
|Videos|April 24, 2014
Reimbursement Changes for Compounded Medications
David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses changes in insurance reimbursement for compounded medications.
Advertisement
In this video, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists (IACP), discusses changes in insurance reimbursement for compounded medications.
This video was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Declines to Review Moderna’s mRNA-1010 Flu Vaccine Application, Citing Comparator Concerns
2
Bipartisan Legislation Introduced to Control Drug Prices, ‘Corporate Greed’ Within Health Care
3
FDA Rolls Back Some Requirements for Isotretinoin-Containing Treatments for Acne
4
FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Products
5








































